Stock 1952 EVEREST MEDICINES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Everest Medicines Limited

Equities

1952

KYG3224E1061

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:06 2024-04-30 am EDT 		5-day change 1st Jan Change
24.45 HKD +2.52% Intraday chart for Everest Medicines Limited +4.71% +16.99%
Apr. 25 Everest Medicines' Loss Widens in 2023 MT
Mar. 28 Everest Medicines Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Everest Medicines and Gilead Sciences Jointly Announce Phase 2B Study of Sacituzumab Govitecan Conducted in China of Patients with Metastatic Triple-Negative Breast Cancer Meets Primary Overall Response Rate Endpoint
CI
EVEREST MEDICINES : Nomura Starts Everest Medicines at Buy With HK$110 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1952 Stock
  4. News Everest Medicines Limited
  5. Analyst Reco.